{
  "basic_data": [
    {
      "cell_line_alt_name": "HPIi005-B; RYR1-5-9214-iPSC clone R11",
      "cell_type": "hiPSC",
      "frozen": "True"
    }
  ],
  "generator": [
    {
      "group": "Harry Perkins Institute of Medical Research"
    }
  ],
  "contact": [
    {
      "group": "Harry Perkins Institute of Medical Research",
      "first_name": "Joshua",
      "last_name": "Clayton",
      "name_initials": "J",
      "e_mail": "joshua.clayton@perkins.org.au",
      "phone_number": "None"
    }
  ],
  "publications": [
    {
      "doi": "10.1016/j.scr.2023.103258",
      "journal": "Stem Cell Research",
      "title": "Generation of two induced pluripotent stem cell lines from a 33-year-old central core disease patient with a heterozygous dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene",
      "first_author": "Karrison Driver",
      "last_author": "Joshua S. Clayton",
      "year": "2023",
      "pmid": "None"
    }
  ],
  "donor": [
    {
      "age": "33",
      "sex": "M",
      "disease_name": "Central core disease",
      "disease_description": "Central core disease (CCD) is a congenital disorder that results in hypotonia, delayed motor development, and areas of reduced oxidative activity in the muscle fibers."
    }
  ],
  "genomic_modifications": [
    {
      "mutation_type": "Spontaneous variant",
      "cytoband": "None",
      "delivery_method": "None",
      "description": "c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene",
      "genotype": "None",
      "loci_name": "RYR1"
    }
  ],
  "differentiation_results": [
    {
      "cell_type": "ME",
      "show_potency": "True",
      "marker_list": "TBXT; BMP4",
      "method_used": "RT-qPCR",
      "differentiation_profile": "in vitro directed differentiation"
    },
    {
      "cell_type": "EC",
      "show_potency": "True",
      "marker_list": "OTX2; PAX6",
      "method_used": "RT-qPCR",
      "differentiation_profile": "in vitro directed differentiation"
    },
    {
      "cell_type": "EN",
      "show_potency": "True",
      "marker_list": "SOX17; GATA4",
      "method_used": "RT-qPCR",
      "differentiation_profile": "in vitro directed differentiation"
    }
  ],
  "undifferentiated_characterisation": [
    {
      "epi_pluri_score": "None",
      "pluri_test_score": "None",
      "pluri_novelty_score": "None"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "16",
      "karyotype": "46,XY",
      "karyotype_method": "GB",
      "summary": "No statistically significant chromosomal abnormalities were detected."
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_type_term": "EBV-immortalised lymphoblastoid cell line (LCL)",
      "i_source_cell_origin_term": "blood",
      "derivation_year": "2022",
      "non_int_vector": "SV",
      "non_int_vector_name": "CytoTune-iPS 2.0 Sendai reprogramming kit"
    }
  ],
  "embryonic_derivation": [],
  "ethics": [
    {
      "ethics_number": "IE-2018-936",
      "approval_date": "None",
      "institutional_HREC": "University of Western Australia's Human Research Ethics Committee"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "21",
      "passage_method": "None"
    }
  ]
}